GE HealthCare Technologies Inc. (NASDAQ:GEHC) Receives Average Rating of “Moderate Buy” from Brokerages

GE HealthCare Technologies Inc. (NASDAQ:GEHC) has been given an average recommendation of “Moderate Buy” by the fourteen research firms that are currently covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, five have given a hold recommendation, seven have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month target price among brokerages that have covered the stock in the last year is $94.23.

A number of analysts have recently issued reports on GEHC shares. JPMorgan Chase & Co. started coverage on GE HealthCare Technologies in a research report on Monday, September 9th. They issued a “neutral” rating and a $90.00 price objective for the company. Redburn Atlantic raised shares of GE HealthCare Technologies to a “strong-buy” rating in a research report on Thursday, August 1st. BTIG Research raised shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 price objective on the stock in a research report on Wednesday, September 18th. Evercore ISI lifted their target price on shares of GE HealthCare Technologies from $98.00 to $102.00 and gave the stock an “outperform” rating in a report on Tuesday, October 1st. Finally, UBS Group cut shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and lowered their price target for the company from $84.00 to $74.00 in a report on Thursday, September 26th.

GE HealthCare Technologies Trading Up 0.6 %

NASDAQ GEHC opened at $91.34 on Friday. GE HealthCare Technologies has a 12 month low of $62.35 and a 12 month high of $94.55. The company has a current ratio of 1.06, a quick ratio of 0.82 and a debt-to-equity ratio of 1.05. The stock has a 50 day moving average of $87.91 and a 200-day moving average of $83.39. The company has a market cap of $41.69 billion, a PE ratio of 26.71, a PEG ratio of 3.39 and a beta of 1.18.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Wednesday, July 31st. The company reported $1.00 EPS for the quarter, beating analysts’ consensus estimates of $0.98 by $0.02. GE HealthCare Technologies had a net margin of 8.10% and a return on equity of 25.26%. The company had revenue of $4.84 billion during the quarter, compared to the consensus estimate of $4.88 billion. During the same quarter last year, the firm posted $0.92 EPS. The company’s quarterly revenue was up .5% on a year-over-year basis. On average, equities research analysts anticipate that GE HealthCare Technologies will post 4.26 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be issued a $0.03 dividend. The ex-dividend date is Friday, October 18th. This represents a $0.12 annualized dividend and a yield of 0.13%. GE HealthCare Technologies’s dividend payout ratio is presently 3.51%.

Insider Buying and Selling

In other GE HealthCare Technologies news, CEO Thomas J. Westrick sold 2,750 shares of the stock in a transaction dated Wednesday, August 7th. The stock was sold at an average price of $80.78, for a total transaction of $222,145.00. Following the completion of the sale, the chief executive officer now directly owns 17,509 shares in the company, valued at approximately $1,414,377.02. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. 0.27% of the stock is owned by insiders.

Institutional Trading of GE HealthCare Technologies

Several large investors have recently modified their holdings of GEHC. Pathway Financial Advisers LLC acquired a new position in GE HealthCare Technologies during the 1st quarter worth approximately $25,000. Fred Alger Management LLC bought a new position in shares of GE HealthCare Technologies in the 2nd quarter worth $26,000. BNP Paribas bought a new stake in GE HealthCare Technologies during the 1st quarter valued at $30,000. Riverview Trust Co acquired a new position in GE HealthCare Technologies during the first quarter worth $31,000. Finally, Elkhorn Partners Limited Partnership bought a new position in shares of GE HealthCare Technologies in the second quarter valued at $31,000. Institutional investors and hedge funds own 82.06% of the company’s stock.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.